Galecto, Inc. financial data

Symbol
GLTO on Nasdaq
Industry
Pharmaceutical Preparations
Location
75 State Street, Suite 100, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 19, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 803 % +93.8%
Debt-to-equity 13.3 % -54.6%
Return On Equity -96.9 % -3.43%
Return On Assets -85.5 % -18%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.32M shares -95.1%
Common Stock, Shares, Outstanding 1.32M shares +21.4%
Entity Public Float 12.3M USD -79.1%
Weighted Average Number of Shares Outstanding, Basic 1.16M shares +8.87%
Weighted Average Number of Shares Outstanding, Diluted 1.16M shares +8.87%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 6.4M USD -73.1%
General and Administrative Expense 10.5M USD -17.2%
Operating Income (Loss) -22.3M USD +44.2%
Nonoperating Income (Expense) 862K USD -44.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.88M USD +52.4%
Income Tax Expense (Benefit) 7K USD
Net Income (Loss) Attributable to Parent -21.4M USD +44.1%
Earnings Per Share, Basic -18.5 USD/shares +48.6%
Earnings Per Share, Diluted -18.5 USD/shares +48.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.2M USD -34%
Marketable Securities, Current 6.08M USD -78.4%
Assets, Current 16.8M USD -54.2%
Property, Plant and Equipment, Net 57K USD -26.9%
Operating Lease, Right-of-Use Asset 73K USD -70.4%
Other Assets, Noncurrent 163K USD -85.6%
Assets 17.1M USD -55.2%
Accounts Payable, Current 377K USD -77.9%
Employee-related Liabilities, Current 204K USD -79.3%
Accrued Liabilities, Current 820K USD -80.1%
Liabilities, Current 1.2M USD -79.5%
Operating Lease, Liability, Noncurrent 61K USD -7.58%
Other Liabilities, Noncurrent 43K USD
Liabilities 1.3M USD -77.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 97K USD -74.5%
Retained Earnings (Accumulated Deficit) -278M USD -8.37%
Stockholders' Equity Attributable to Parent 15.8M USD -51%
Liabilities and Equity 17.1M USD -55.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -5.94M USD +35%
Net Cash Provided by (Used in) Financing Activities 23K USD
Net Cash Provided by (Used in) Investing Activities 5.65M USD +311%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 1.32M shares +21.4%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 14.2M USD -34%
Deferred Tax Assets, Valuation Allowance 67.2M USD +6.02%
Deferred Tax Assets, Gross 67.2M USD +6.02%
Operating Lease, Liability 73K USD -70.7%
Depreciation 21K USD -92.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -21.7M USD +42.4%
Lessee, Operating Lease, Liability, to be Paid 89K USD -65.5%
Property, Plant and Equipment, Gross 107K USD 0%
Operating Lease, Liability, Current 12K USD -93.4%
Lessee, Operating Lease, Liability, to be Paid, Year Two 18K USD +5.88%
Lessee, Operating Lease, Liability, to be Paid, Year One 18K USD -92.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 16K USD +77.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18K USD
Deferred Tax Assets, Operating Loss Carryforwards 55.2M USD +5.34%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 18K USD
Operating Lease, Payments 223K USD -60.5%
Additional Paid in Capital 292M USD +1.34%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 3.24M USD -40.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%